See more : Spectra7 Microsystems Inc. (SPVNF) Income Statement Analysis – Financial Results
Complete financial analysis of Can B Corp. (CANB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Can B Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Frontier Lithium Inc. (HL2.F) Income Statement Analysis – Financial Results
- Itoham Yonekyu Holdings Inc. (2296.T) Income Statement Analysis – Financial Results
- Zhenjiang Dongfang Electric Heating Technology Co.,Ltd (300217.SZ) Income Statement Analysis – Financial Results
- TV Thunder Public Company Limited (TVT.BK) Income Statement Analysis – Financial Results
- BASO Precision Optics Co., LTD (6517.TWO) Income Statement Analysis – Financial Results
Can B Corp. (CANB)
About Can B Corp.
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.16M | 6.69M | 4.60M | 1.71M | 2.31M | 668.60K | 122.75K | 95.15K | 103.04K | 32.57K | 16.36K | 24.10K | 2.07K | 22.90K |
| Cost of Revenue | 1.80M | 4.07M | 1.61M | 278.06K | 598.58K | 405.53K | 44.47K | 72.30K | 0.00 | 404.00 | 2.24K | 404.00 | 15.41K | 14.34K |
| Gross Profit | 358.70K | 2.61M | 2.99M | 1.43M | 1.71M | 263.07K | 78.28K | 22.84K | 103.04K | 32.17K | 14.12K | 23.69K | -13.34K | 8.56K |
| Gross Profit Ratio | 16.64% | 39.11% | 64.99% | 83.74% | 74.04% | 39.35% | 63.77% | 24.01% | 100.00% | 98.76% | 86.31% | 98.32% | -645.28% | 37.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 165.00K | 150.00K | 75.00K | 37.00K | 0.00 | 276.99K | 1.03K | 140.91K | 0.00 | 0.00 | 9.05K |
| General & Administrative | 4.75M | 13.54M | 9.64M | 4.61M | 5.80M | 3.59M | 599.75K | 424.81K | 1.61M | 58.76K | 328.33K | 1.67M | 1.13M | 1.08M |
| Selling & Marketing | 0.00 | 0.00 | 3.62M | 519.92K | 333.44K | 84.32K | 28.32K | 11.90K | 15.65K | 0.00 | 0.00 | 0.00 | 0.00 | 17.18K |
| SG&A | 4.75M | 13.54M | 13.26M | 5.13M | 6.14M | 3.67M | 628.08K | 436.71K | 1.61M | 58.76K | 328.33K | 1.67M | 1.13M | 1.10M |
| Other Expenses | 3.10M | 3.24M | 13.26M | 665.39K | 154.72K | -735.09K | 162.99K | 7.24K | 4.96K | 0.00 | 0.00 | 0.00 | 266.00 | 2.56K |
| Operating Expenses | 7.85M | 16.78M | 13.26M | 5.80M | 6.29M | 3.68M | 791.07K | 443.95K | 1.62M | 58.76K | 328.33K | 1.67M | 1.13M | 1.11M |
| Cost & Expenses | 9.64M | 20.85M | 14.87M | 6.07M | 6.89M | 4.08M | 835.53K | 443.95K | 1.62M | 59.16K | 330.57K | 1.67M | 1.15M | 1.13M |
| Interest Income | 0.00 | 902.13K | 2.10M | 934.68K | 2.52K | 10.33K | 2.84K | 1.17K | 127.00 | 1.00 | 1.00 | 58.00 | 63.00 | 0.00 |
| Interest Expense | 2.51M | 902.13K | 2.10M | 934.68K | 8.79K | 263.51K | 279.22K | 56.23K | 48.67K | 1.00 | 6.28K | 10.74K | 5.54K | 9.72K |
| Depreciation & Amortization | 1.40M | 1.43M | 542.35K | 783.30K | 231.87K | 5.47K | 7.20K | 7.24K | 4.96K | 3.40K | 2.99K | 10.79K | 15.67K | 18.95K |
| EBITDA | -5.82M | -12.59M | -9.52M | -7.16M | -5.66M | -3.84M | -1.85M | -601.58K | -3.54M | -26.24K | -311.22K | -1.65M | -1.13M | -1.09M |
| EBITDA Ratio | -269.84% | -190.57% | -211.14% | -209.46% | -188.67% | -618.46% | -572.52% | -357.77% | -1,464.60% | -71.22% | -1,902.81% | -6,840.67% | -54,586.70% | -4,741.21% |
| Operating Income | -7.49M | -14.17M | -10.27M | -4.36M | -4.58M | -3.42M | -712.79K | -411.55K | -1.83M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Operating Income Ratio | -347.28% | -211.92% | -222.99% | -255.28% | -198.83% | -510.88% | -580.70% | -432.55% | -1,778.60% | -81.65% | -1,959.52% | -6,885.46% | -55,612.72% | -4,877.56% |
| Total Other Income/Expenses | -2.24M | -755.24K | -1.90M | -1.34M | -6.27K | -696.50K | -1.43M | -253.50K | -2.02M | 51.00 | 1.00 | 58.00 | 0.00 | 0.00 |
| Income Before Tax | -9.73M | -14.92M | -12.17M | -5.71M | -4.59M | -4.11M | -2.14M | -665.05K | -3.85M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Income Before Tax Ratio | -451.25% | -223.22% | -264.31% | -334.17% | -199.11% | -615.06% | -1,743.21% | -698.99% | -3,734.76% | -81.64% | -1,959.51% | -6,883.54% | -55,612.72% | -4,877.56% |
| Income Tax Expense | 9.60K | 793.00 | 1.08K | 3.30K | 2.08K | -432.99K | 279.22K | 56.23K | 48.67K | 1.00 | 6.28K | -58.00 | 5.54K | 9.72K |
| Net Income | -9.74M | -14.92M | -12.17M | -5.72M | -4.59M | -4.11M | -2.14M | -665.05K | -3.85M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Net Income Ratio | -451.70% | -223.23% | -264.33% | -334.36% | -199.20% | -615.06% | -1,743.21% | -698.99% | -3,734.76% | -81.64% | -1,959.51% | -6,883.54% | -55,612.72% | -4,877.56% |
| EPS | -0.77 | -4.18 | -9.06 | -24.26 | -33.46 | -43.66 | -58.28 | -20.55 | -80.67 | -0.67 | -8.13 | -42.70 | -32.67 | -9.55K |
| EPS Diluted | -0.77 | -4.18 | -9.06 | -24.26 | -33.46 | -43.66 | -37.57 | -12.73 | -80.67 | -0.67 | -8.13 | -42.70 | -32.67 | -9.55K |
| Weighted Avg Shares Out | 12.59M | 3.57M | 1.34M | 235.65K | 137.25K | 94.19K | 36.71K | 32.37K | 47.71K | 39.57K | 39.43K | 38.85K | 35.19K | 117.00 |
| Weighted Avg Shares Out (Dil) | 12.59M | 3.57M | 1.34M | 235.65K | 137.25K | 94.19K | 56.95K | 52.24K | 47.71K | 39.57K | 39.43K | 38.85K | 35.19K | 117.00 |
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”) today announced that it has implemented a reorganization in which a new holding company,...
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
The Patents Term – Presumed Valid By Law – Extends to 2035 HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation ( OTCQB: CANB ) (“Can B”), a health and wellness company...
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
HICKSVILLE, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. ( OTCQB: CANB ) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its move and consolidation...
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
Processing Has Already Started HICKSVILLE, NY, July 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is...
Can B Corp. Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee
HICKSVILLE, NY / ACCESSWIRE / August 25, 2021 / Can B Corp. (OTCQB:CANB) ('Can B' or the 'Company'), a diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce...
Can B Corp. Strengthens Its Vertical Processing Capabilities With Acquisition of Assets From Music City Botanicals
HICKSVILLE, NY, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp. (OTCQB: CANB) (“CAN B” or the “Company”), diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce its...
Can B Corp. Closes Acquisition of Assets from Music City Botanicals to Strengthen its Vertical Processing Capabilities
HICKSVILLE, NY / ACCESSWIRE / August 19, 2021 / Can B Corp. (OTCQB:CANB) ('CAN B' or the 'Company'), a diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce...
Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
HICKSVILLE, NY / ACCESSWIRE / August 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing and selling hemp derived cannabinoid products, today announced the Company's financial results for...
Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
Adds $5 Million in Processing Assets HICKSVILLE, NY / ACCESSWIRE / August 17, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company specializing in the development, production and sale of products containing...
Can B Corp Announces First Quarter 2021 Results
- Strengthened Balance Sheet with $1.7 Million Cash Balance - Strong Gross Margin of 75% HICKSVILLE, NY / ACCESSWIRE / May 22, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") a diversified health and wellness company, announced...
Source: https://incomestatements.info
Category: Stock Reports